Axonis

Neuro-focused biotechnology company developing first-in-class KCC2 therapies

Built from URL

Boston

HealthcarePharmaceuticals & MedicineNeuroscienceBiotechDrug Discovery

MassChallengeBoston 2019

AboutBuilt from URL

Axonis Therapeutics is a Boston-based biotechnology company developing first- and best-in-class neuromedicines targeting KCC2, the critical mediator of inhibition within the brain. The company focuses on translating breakthrough discoveries from Boston Children's Hospital, Harvard and Laval University into treatments for neurological disorders.

ProblemBuilt from URL

See something off about this company?